Influx Healthtech Ltd

NSE: INFLUX · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹274.30
Market cap: ₹635.0 Cr
Revenue (annual): ₹146.8 Cr
Net profit (annual): ₹20.54 Cr
P/E (TTM): 30.9×Sector 47.3×
Promoter holding: 73.53%
FII holding: 0.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Earnings Call 3 Other Announcement 2 Financial Results 2 Results Update 1 Management Change 1 Legal & Regulatory 1 Fund Raise 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 10:55 IST NSE

Debt & Borrowing

Influx Healthtech Debt & Borrowing

Influx Healthtech Limited informed the exchange that it does not qualify as a 'Large Corporate' as of March 31, 2026. The company reported zero outstanding long-term borrowings and stated that credit rating criteria were not applicable, ensuring compliance with SEBI debt-raising norms.

Read the filing ↗